Dr. Levine on Evolving Treatment Options for Patients With mCRPC
September 5th 2016Richard M. Levine, MD, medical director, Moffitt International Plaza, Moffitt Cancer Center, discusses the available agents and their benefits for patients with metastatic castration-resistant prostate cancer.
Read More